Article
Author(s):
Washington-As Congress moves toward possible approval of a new prescriptiondrug program for Medicare recipients later this summer, determination ofpayments for cancer drugs and therapeutic services may well hang in thebalance.
Clarifying coding for percutaneous nephrolithotomy procedures
Urology Coding Q&A: Can G2211 be reported regardless of payer?